Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $12,488 | 569 | 77.5% |
| Consulting Fee | $2,165 | 1 | 13.4% |
| Travel and Lodging | $965.50 | 1 | 6.0% |
| Education | $498.20 | 9 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GENZYME CORPORATION | $4,002 | 25 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $2,384 | 84 | $0 (2023) |
| GlaxoSmithKline, LLC. | $2,151 | 174 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,322 | 71 | $0 (2023) |
| Grifols USA, LLC | $555.88 | 17 | $0 (2023) |
| Mallinckrodt Hospital Products Inc. | $510.40 | 20 | $0 (2023) |
| Regeneron Healthcare Solutions, Inc. | $441.45 | 20 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $402.71 | 7 | $0 (2024) |
| Genentech USA, Inc. | $366.42 | 20 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $365.94 | 28 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $286.39 | 3 | JAZZ PHARMACEUTICALS INC. ($134.30) |
| 2023 | $5,492 | 87 | GENZYME CORPORATION ($3,410) |
| 2022 | $2,734 | 107 | AstraZeneca Pharmaceuticals LP ($622.34) |
| 2021 | $1,293 | 79 | AstraZeneca Pharmaceuticals LP ($392.85) |
| 2020 | $910.31 | 42 | AstraZeneca Pharmaceuticals LP ($213.26) |
| 2019 | $2,280 | 102 | Boehringer Ingelheim Pharmaceuticals, Inc. ($378.78) |
| 2018 | $2,080 | 91 | GlaxoSmithKline, LLC. ($359.28) |
| 2017 | $1,039 | 69 | GlaxoSmithKline, LLC. ($361.98) |
All Payment Transactions
580 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/17/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $129.64 | General |
| 03/08/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $22.45 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/21/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $134.30 | General |
| Category: NEUROLOGY | ||||||
| 11/16/2023 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $18.36 | General |
| Category: Pulmonology | ||||||
| 11/16/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $6.32 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $23.26 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 11/15/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $10.53 | General |
| Category: RESPIRATORY | ||||||
| 11/15/2023 | Inogen, Inc. | INOGEN ONE G5 OXYGEN CONCENTRATOR - BLUETOOTH (Device) | Food and Beverage | Cash or cash equivalent | $0.59 | General |
| Category: OXYGEN CONCENTRATOR | ||||||
| 11/13/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $0.63 | General |
| Category: RESPIRATORY | ||||||
| 11/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.05 | General |
| Category: RESPIRATORY | ||||||
| 10/24/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.09 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2023 | AstraZeneca Pharmaceuticals LP | TAGRISSO (Drug) | Food and Beverage | In-kind items and services | $123.50 | General |
| Category: Oncology | ||||||
| 10/12/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | STIOLTO RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: RESPIRATORY | ||||||
| 10/10/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $12.06 | General |
| Category: RESPIRATORY | ||||||
| 10/09/2023 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.01 | General |
| Category: RESPIRATORY | ||||||
| 09/28/2023 | Pulmonx Corporation | CHARTIS CATHETER (Device), ZEPHYR DELIVERY CATHETER, ZEPHYR ENDOBRONCHIAL VALVE | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: PULMONOLOGY | ||||||
| 09/28/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $6.64 | General |
| Category: RESPIRATORY | ||||||
| 09/27/2023 | Amgen Inc. | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: Inflammation | ||||||
| 09/27/2023 | Mallinckrodt Hospital Products Inc. | ACTHAR (Biological) | Food and Beverage | In-kind items and services | $8.00 | General |
| Category: IMMUNOLOGY | ||||||
| 09/25/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $28.31 | General |
| Category: RESPIRATORY | ||||||
| 09/20/2023 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $24.87 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/19/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $27.70 | General |
| Category: IMMUNOLOGY | ||||||
| 09/13/2023 | Philips Electronics North America Corporation | (8874) inCourage (Device) | Food and Beverage | Cash or cash equivalent | $16.21 | General |
| Category: Medical Device | ||||||
| 09/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SPIRIVA RESPIMAT (Drug) | Food and Beverage | In-kind items and services | $5.79 | General |
| Category: RESPIRATORY | ||||||
| 09/06/2023 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $15.22 | General |
| Category: IMMUNOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,398 | 2,211 | $425,778 | $213,306 |
| 2022 | 14 | 1,474 | 2,479 | $511,913 | $261,635 |
| 2021 | 16 | 1,591 | 2,532 | $552,014 | $278,858 |
| 2020 | 15 | 1,957 | 3,186 | $587,063 | $307,094 |
All Medicare Procedures & Services
57 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 151 | 365 | $132,495 | $62,778 | 47.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 282 | 630 | $85,050 | $59,817 | 70.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 199 | 321 | $62,595 | $29,721 | 47.5% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 174 | 183 | $48,678 | $24,559 | 50.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 188 | 296 | $35,565 | $18,490 | 52.0% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 96 | 99 | $13,365 | $4,016 | 30.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 33 | 33 | $8,415 | $3,998 | 47.5% |
| 94726 | Test to determine lung volumes using sensors | Office | 2023 | 96 | 99 | $9,900 | $3,803 | 38.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 96 | 99 | $13,365 | $2,809 | 21.0% |
| 94618 | Test for exercise-induced lung stress | Office | 2023 | 51 | 54 | $12,150 | $1,311 | 10.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 18 | $2,520 | $1,152 | 45.7% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 14 | 14 | $1,680 | $851.76 | 50.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 183 | 470 | $170,610 | $83,841 | 49.1% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 328 | 777 | $104,895 | $64,013 | 61.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 228 | 362 | $70,650 | $34,648 | 49.0% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 191 | 195 | $51,870 | $30,341 | 58.5% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 189 | 297 | $35,640 | $17,013 | 47.7% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 16 | 19 | $16,644 | $9,205 | 55.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 11 | 13 | $10,842 | $6,021 | 55.5% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 79 | 84 | $11,340 | $3,704 | 32.7% |
| 94726 | Test to determine lung volumes using sensors | Office | 2022 | 79 | 84 | $8,400 | $3,471 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 26 | 26 | $6,630 | $3,409 | 51.4% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 79 | 84 | $11,340 | $2,482 | 21.9% |
| 31500 | Emergent insertion of breathing tube into windpipe using an endoscope | Facility | 2022 | 11 | 11 | $1,672 | $1,316 | 78.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 17 | 17 | $2,380 | $1,099 | 46.2% |
About Dr. Kurt Bowman, MD
Dr. Kurt Bowman, MD is a Critical Care Medicine healthcare provider based in Orange City, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/10/2008. The National Provider Identifier (NPI) number assigned to this provider is 1578727343.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kurt Bowman, MD has received a total of $16,117 in payments from pharmaceutical and medical device companies, with $286.39 received in 2024. These payments were reported across 580 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($12,488).
As a Medicare-enrolled provider, Bowman has provided services to 6,420 Medicare beneficiaries, totaling 10,408 services with total Medicare billing of $1.1M. Data is available for 4 years (2020–2023), covering 57 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease
- Location Orange City, FL
- Active Since 07/10/2008
- Last Updated 06/11/2025
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1578727343
Products in Payments
- DUPIXENT (Biological) $4,284
- TRELEGY ELLIPTA (Drug) $945.63
- OFEV (Drug) $631.10
- NUCALA (Biological) $614.10
- ACTHAR (Biological) $571.52
- FASENRA (Biological) $466.02
- BEVESPI AEROSPHERE (Drug) $373.50
- TAGRISSO (Drug) $372.23
- Prolastin-C Liquid (Biological) $356.62
- STIOLTO RESPIMAT (Drug) $324.17
- BREZTRI (Drug) $315.95
- ANORO (Drug) $302.17
- TEZSPIRE (Biological) $301.10
- Esbriet (Biological) $282.38
- XYWAV (Drug) $276.00
- Nephrocheck (Device) $226.97
- NEPHROCHECK TEST (Device) $208.61
- IMFINZI (Biological) $178.35
- Utibron (Drug) $177.29
- (8874) inCourage (Device) $174.34
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Orange City
Radhika Verma, Md, MD
Critical Care Medicine — Payments: $18,454
Paul Smith, Md, MD
Critical Care Medicine — Payments: $10,674
Mrs. Shahana Masood, M.d, M.D
Critical Care Medicine — Payments: $10,597
Kristal Carthan, Md, MD
Critical Care Medicine — Payments: $8,413
Arianne Bennett-Venner, Md, MD
Critical Care Medicine — Payments: $7,575
Edward Scanlon, Md, MD
Critical Care Medicine — Payments: $3,567